Woodward Lab

Schizophrenia is often a chronic, debilitating illness that affects about 1% of the population. People with schizophrenia experience psychotic symptoms like hallucinations and delusions, negative symptoms, including social withdrawal, and have problems with thinking skills like attention, reasoning and problem solving, and memory. The Woodward Lab investigates how the brain is affected in schizophrenia and other psychotic disorders. We are especially interested in understanding why individuals with schizophrenia have cognitive problems and if the cognitive deficits can be alleviated. We use a variety of methods to investigate brain function, including neuroimaging, neuropsychological testing, and cognitive neuroscience experiments. Ultimately, we hope that our work will shed light on the neural basis of schizophrenia, contribute to the development of better treatments, and improve the lives of those affected by this illness. The Woodward Lab has received funding support from the National Institute of Mental Health (NIMH), the Brain and Behavior Research Fund, the Luton Society, the Vanderbilt Psychiatric Genotype/Phenotype Project, and the Jack Martin MD, Research Professorship in Psychopharmacology.

For more information on our research, click on the “Research” link at the top of this page.

Our laboratory is affiliated with the Vanderbilt Early Psychosis Program and the Center for Cognitive Medicine in the Department of Psychiatry.